These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25459104)

  • 1. Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine.
    Stoops WW; Pike E; Hays LR; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2015 Feb; 129():45-50. PubMed ID: 25459104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine.
    Marks KR; Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
    J Clin Psychopharmacol; 2016 Jun; 36(3):213-21. PubMed ID: 27043121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder.
    Mooney LJ; Hillhouse MP; Thomas C; Ang A; Sharma G; Terry G; Chang L; Walker R; Trivedi M; Croteau D; Sparenborg S; Ling W
    J Addict Med; 2016; 10(4):236-43. PubMed ID: 27379819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine.
    Reynolds AR; Strickland JC; Stoops WW; Lile JA; Rush CR
    Drug Alcohol Depend; 2017 Dec; 181():25-29. PubMed ID: 29028556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users.
    Marks KR; Lile JA; Stoops WW; Rush CR
    Psychopharmacology (Berl); 2014 Jul; 231(14):2741-50. PubMed ID: 24464531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bupropion and Naltrexone in Methamphetamine Use Disorder.
    Trivedi MH; Walker R; Ling W; Dela Cruz A; Sharma G; Carmody T; Ghitza UE; Wahle A; Kim M; Shores-Wilson K; Sparenborg S; Coffin P; Schmitz J; Wiest K; Bart G; Sonne SC; Wakhlu S; Rush AJ; Nunes EV; Shoptaw S
    N Engl J Med; 2021 Jan; 384(2):140-153. PubMed ID: 33497547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of the naltrexone/bupropion combination for the treatment of obesity: an update.
    Christou GA; Kiortsis DN
    Hormones (Athens); 2015; 14(3):370-5. PubMed ID: 26188223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm.
    Rukstalis M; Jepson C; Strasser A; Lynch KG; Perkins K; Patterson F; Lerman C
    Psychopharmacology (Berl); 2005 Jun; 180(1):41-8. PubMed ID: 15682300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash.
    Wright FL; Rodgers RJ
    Psychopharmacology (Berl); 2013 Jul; 228(2):291-307. PubMed ID: 23455599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone-bupropion combinations do not affect cocaine self-administration in humans.
    Regnier SD; Stoops WW; Lile JA; Alcorn JL; Bolin BL; Reynolds AR; Hays LR; Rayapati AO; Rush CR
    Pharmacol Biochem Behav; 2023 Mar; 224():173526. PubMed ID: 36805862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.
    Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR
    Psychopharmacology (Berl); 2011 Apr; 214(3):665-74. PubMed ID: 21072503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
    Ray LA; Bujarski S; Courtney KE; Moallem NR; Lunny K; Roche D; Leventhal AM; Shoptaw S; Heinzerling K; London ED; Miotto K
    Neuropsychopharmacology; 2015 Sep; 40(10):2347-56. PubMed ID: 25801501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication Adherence Monitoring Using Smartphone Video Dosing in an Open-label Pilot Study of Monthly Naltrexone Plus Once-daily Bupropion for Methamphetamine Use Disorder: Feasibility and Acceptability.
    Walker R; Hillhouse M; Perrochet B; Sparenborg S; Mooney L; Ling W
    J Addict Med; 2019; 13(5):372-378. PubMed ID: 30724759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Greenway FL; Fujioka K; Plodkowski RA; Mudaliar S; Guttadauria M; Erickson J; Kim DD; Dunayevich E;
    Lancet; 2010 Aug; 376(9741):595-605. PubMed ID: 20673995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute physiological and behavioral effects of intranasal methamphetamine in humans.
    Hart CL; Gunderson EW; Perez A; Kirkpatrick MG; Thurmond A; Comer SD; Foltin RW
    Neuropsychopharmacology; 2008 Jul; 33(8):1847-55. PubMed ID: 17851535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial.
    Wadden TA; Foreyt JP; Foster GD; Hill JO; Klein S; O'Neil PM; Perri MG; Pi-Sunyer FX; Rock CL; Erickson JS; Maier HN; Kim DD; Dunayevich E
    Obesity (Silver Spring); 2011 Jan; 19(1):110-20. PubMed ID: 20559296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine self-administration in humans during D-amphetamine maintenance.
    Pike E; Stoops WW; Hays LR; Glaser PE; Rush CR
    J Clin Psychopharmacol; 2014 Dec; 34(6):675-81. PubMed ID: 25154010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone does not attenuate the acute behavioral effects of ethanol or pentobarbital in humans.
    Rush CR; Ali JA
    Behav Pharmacol; 1999 Jul; 10(4):401-13. PubMed ID: 10780808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial.
    Schmitz JM; Stotts AL; Yoon JH; Northrup TF; Villarreal YR; Yammine L; Weaver MF; Carmody T; Shoptaw S; Trivedi MH
    J Subst Use Addict Treat; 2023 Aug; 151():208987. PubMed ID: 36822269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with naltrexone and bupropion for obesity.
    Billes SK; Greenway FL
    Expert Opin Pharmacother; 2011 Aug; 12(11):1813-26. PubMed ID: 21689063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.